RE:RE:RE:RE:Accelerated Approval99942Apophis wrote: Rumpl3StiltSkin wrote 99942Apophis wrote: A side play I've been considering more so lately with large pharmas being removed from Accelerated Approval voluntarily or not is somewhere down the line IF this company (TLT) starts to eat into big pharma's cancer related revenue a bear pharmaceutical ETF could be worthwhile. Mind you I will only buy into that or maybe look at the most vulnerable ones and pick up some options. Anyone else here with those thoughts?
I think a ton of this stimulus is going to find it's way back into the stock market, one prognosticator has pointed out that the biotechs have lagged the rest of the stocks so far in this broad rally. Also, small caps. I'd wait to short the market at least 18 months. Maybe 2 yrs for biotechs/small caps. This stim money will take time to work through.
Great point Rumpl3StiltSkin I didn't consider stimulus effect which could make a bear ETF more desirable to buy over options if we see a rush to pick up big pharma making a bear ETF very cheap, at that time frame (TLT) of well over a year and with good CR from this trial then Lung with Brain underway the stock price will have moved up considerably. To siphon off some profit from here and picking up a bear pharma I would be eating big pharma's lunch. Just a thought in my uneducated opinion.
I've thought the overall market has been in bubble terriroty for a while, yet it could have a ways to go before it pops. I do like your idea that a bear Pharma ETF will be a good play, in about a year. I think any big move into biotechs will sympathetically support Big Pharma for a while.